Archives

by in
Entry Author Date Location
Aveo, Mersana, Haemonetics, & More from the Boston Life Sciences Roundup 08/03/12 Boston
Brightcove, Avalon, Bit9, & More from the Boston Deals Roundup 08/01/12 Boston
Mersana Brings in $27M and New Investors NEA and Pfizer 07/31/12 Boston
Mersana Therapeutics Secures $27,000,000 Series A Funding 07/31/12 Boston
Mersana Adds $4M For Next-Generation “Armed” Cancer Drugs 05/01/12 Boston
Liazon Receives $18,200,000 New Funding Round 04/24/12 New York
EnVivo Posts Positive Trial of Schizophrenia Drug 12/05/11 Boston
Imagen Biotech, Staffed With Eyetech Vets, Launches in NYC With Plan to Tackle Eye Diseases 10/25/11 New York
Biotech Funding in New York: We Have Some Catching Up to Do 10/21/11 New York
Fluidnet Finds $25M 08/12/11 Boston
EnVivo, Backed by Fidelity Biosciences, Tests New Weapon Against Alzheimer’s 07/25/11 Boston
Ultragenyx Pharmaceutical Lands $45,000,000 Series A Round 06/20/11 San Francisco
Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs 05/25/11 Boston
NextWave Pharma Snaps Up $45M 01/11/11 San Francisco
VMware Makes Two Acquisitions, Mascoma Picks Up SunOpta Unit, Vela Gets $6M, & More Boston-Area Deals News 09/08/10 Boston
Pfizer Gobbles FoldRx in Big Pharma’s Latest Rare Disease Play in Boston Area 09/01/10 Boston
ViewRay Secures $20,000,000 Series C Financing Round 08/25/10 Detroit
Accuri Cytometers Raises $6M for Smaller, Cheaper Cell Analysis Instruments 07/12/10 Detroit
Accuri Cytometers Obtains $6,000,000 Series E Round 07/12/10 Detroit
Polaris Raises $234M for New Fund, BioScale Pins Down $25M, Clinical Data Nets $30M, & More Boston-Area Deals News 06/16/10 Boston
FoldRx Pharma Finds $29M, Plans to Seek Approval of First Drug in 2010 06/15/10 Boston
FoldRx Pharmaceuticals Garners $29,000,000 New Financing 06/15/10 Boston
Zipcar Files for $75M IPO, Tetraphase Gets $45M, Covidien Acquires ev3 for $2.6B, & More Boston-Area Deals News 06/02/10 Boston
Tetraphase Nails $45M Round to Test Pipeline of New Antibiotics 06/01/10 Boston
TetraPhase Pharmaceuticals Receives $45,000,000 Series C Financing 06/01/10 Boston
NeuroTherapeutics Pharma Obtains $43,000,000 Series B Financing 05/20/10 Detroit
Proteostasis, with San Diego Roots and Boston Home, Seeks Edge in Alzheimer’s and Parkinson’s 05/03/10 Boston
Ironwood Pharma CEO Peter Hecht Breaks Silence on Company’s Big Biotech IPO 03/23/10 Boston
Larry Cheng on the Birth of Volition Capital 01/12/10 Boston
Fidelity Ventures Team Forms Volition Capital 01/11/10 Boston
Page 2 of 3 « previous page · next page »